Centrosome cycle studies reveal promising candidates for anti-cancer drug design.
Schmeichel
Karen L
KL
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA. KLSchmeichel@lbl.gov
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D064127:Aurora Kinases; D002453:Cell Cycle / Q000502:physiology*; D018385:Centrosome / Q000378:metabolism*; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism
D000970:Antineoplastic Agents; D064127:Aurora Kinases; D017346:Protein Serine-Threonine Kinases